1. Senate HELP committee grills Novo Nordisk on weight loss drug pricing - September 24, 2024

    Senate HELP committee grills Novo Nordisk on weight loss drug pricing - September 24, 2024

    2
    0
    71
    1
  2. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    3
  3. Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    Novo Nordisk's New Weight Drug Disappoints | World Business Watch

    2
  4. 🚨 $NVO 🚨 Why is Novo Nordisk trending today? 🤔 #NVO #finance #stocks #money

    🚨 $NVO 🚨 Why is Novo Nordisk trending today? 🤔 #NVO #finance #stocks #money

    2
    0
    30
  5. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    18
  6. Novo Nordisk CEO defends high price off Ozempic and Wegovy

    Novo Nordisk CEO defends high price off Ozempic and Wegovy

    4
  7. Earnings Exchange: Supermicro, Novo Nordisk, CVS Health

    Earnings Exchange: Supermicro, Novo Nordisk, CVS Health

    48
  8. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    13
  9. 🚨 $NVO 🚨 Why is Novo Nordisk trending today? 🤔 #NVO #finance #stocks #money

    🚨 $NVO 🚨 Why is Novo Nordisk trending today? 🤔 #NVO #finance #stocks #money

    9
  10. Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture

    2
  11. Novo Nordisk's Rollercoaster Ride: Challenges & Triumphs!

    Novo Nordisk's Rollercoaster Ride: Challenges & Triumphs!

    3
  12. Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market

    Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market

    28
  13. Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market

    Novo Nordisk CEO on Wegovy, Ozempic, Profit Forecast, US Market

    28
  14. Everything Under the Sun: The 225th Evolutionary Lens with Bret Weinstein and Heather Heying

    Everything Under the Sun: The 225th Evolutionary Lens with Bret Weinstein and Heather Heying

    516
    4
    70.1K
    140
  15. Novo Nordisk shares slide as obesity drug maker warns on profit | REUTERS

    Novo Nordisk shares slide as obesity drug maker warns on profit | REUTERS

    35